Provided by Tiger Fintech (Singapore) Pte. Ltd.

Apellis Pharmaceuticals Inc.

22.95
+0.61002.73%
Post-market: 23.040.0944+0.41%19:42 EDT
Volume:4.08M
Turnover:94.14M
Market Cap:2.88B
PE:-12.78
High:23.57
Open:22.26
Low:22.04
Close:22.34
Loading ...
Nov 22, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Nov 08, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 05, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 03, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 08, 2024

Major Issues Report

Form 8-K - Current report
Aug 01, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 21, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 05, 2024

Major Issues Report

Form 8-K - Current report
May 14, 2024

Major Issues Report

Form 8-K - Current report
May 09, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 07, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 09, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 01, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 20, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 19, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 15, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 14, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 08, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 01, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities